Department of Cardiothoracic and Vascular Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas.
Department of Cardiothoracic and Vascular Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas.
Ann Thorac Surg. 2020 Mar;109(3):e187-e189. doi: 10.1016/j.athoracsur.2019.06.098. Epub 2019 Aug 24.
Since its approval by the United States Food and Drug Administration in 2011, transcatheter aortic valve replacement has revolutionized the treatment of aortic valvular disease with a rapid increase in use. Potentially fatal aortic complications are rare, occurring in 0.2% to 1.1% of cases-all reported in the early perioperative period. We present a case of a late ascending aortic pseudoaneurysm with rupture secondary to erosion by an embolized transcatheter aortic valve occurring 6 years after implantation. The patient was successfully treated with a commercially available, off-the-shelf aortic endograft.
自 2011 年获得美国食品和药物管理局批准以来，经导管主动脉瓣置换术已经彻底改变了主动脉瓣疾病的治疗方法，其应用迅速增加。潜在的致命性主动脉并发症很少见，发生率为 0.2%至 1.1%，所有这些并发症均发生在手术早期。我们报告了一例植入 6 年后因栓塞的经导管主动脉瓣侵蚀而导致的迟发性升主动脉假性动脉瘤破裂的病例。该患者成功地接受了一种市售的现成主动脉覆膜支架进行治疗。
